Biogen Sues Company Over Allegedly Selling Knockoff Alzheimer's Treatment

A New York life sciences company has called a patent infringement lawsuit filed by Biogen a “misunderstanding.” Biogen filed a lawsuit against the company over alleged patent infringements related to its experimental Alzheimer’s disease treatment, aducanumab.